- Deltex Medical Group - a global leader in Oesophageal Doppler Monitoring - has announced the addition of a significant new hospital account in the US.

It said the 600 bed teaching hospital initially planned to treat around 40 patients per month within its surgical enhanced recovery programmes.

It said that after the hospital's positive clinical evaluation of ODM was completed in the first half of 2015, implementation was delayed pending a hospital system merger.

It said: 'As a result of the combination, there are now 10 further hospitals in the enlarged system.

'The procurement agreement covers the whole system, providing scope for relatively rapid conversion of future clinical acceptance of ODM into incremental revenues.'

At 8:12am: [LON:DEMG] Deltex Medical Group PLC share price was +0.25p at 3.13p

Story provided by